NCT01476995View on ClinicalTrials.gov

Prognostic Indicators as Provided by the EPIC ClearView

CompletedOBSERVATIONAL
Enrollment

353

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Coronary Artery DiseaseCongestive Heart FailureValvular Heart DiseaseAtrial FibrillationHypertensionPyelonephritisAcute Renal FailureRenal FailureViral HepatitisAlcoholic HepatitisSteatohepatitisCirrhosisAsthmaCOPDBronchitisEmphysemaPneumoniaInflammatory Bowel DiseaseCrohn's DiseaseUlcerative ColitisDiverticulitisPeptic Ulcer DiseaseIrritable Bowel SyndromeCholecystitisPancreatitisMalabsorption DisordersCeliac SprueDiabetes
Trial Locations (1)

21204

Greater Baltimore Medical Cente, Baltimore

Sponsors
All Listed Sponsors
lead

Epic Research & Diagnostics, Inc.

INDUSTRY

NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView | Biotech Hunter | Biotech Hunter